Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MGScience Aps Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.6% 2.3% 1.9% 1.3% 1.1% 1.8% 11.3% 11.0%   Credit score (0-100)   63 66 70 79 84 70 22 22   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.1 17.6 52.7 0.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   167 284 173 848 920 814 0.0 0.0   EBITDA   167 284 173 848 920 814 0.0 0.0   EBIT   93.0 210 99.0 683 755 642 0.0 0.0   Pre-tax profit (PTP)   -65.0 90.0 -197.0 254.0 322.0 74.3 0.0 0.0   Net earnings   -52.0 70.0 -154.0 200.0 252.0 58.8 0.0 0.0   Pre-tax profit without non-rec. items   -65.0 90.0 -197 254 322 74.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,539 3,467 8,703 9,617 9,451 9,313 0.0 0.0   Shareholders equity total   -79.0 -9.0 337 537 789 848 798 798   Interest-bearing liabilities   3,654 3,531 9,751 9,322 8,667 8,152 0.0 0.0   Balance sheet total (assets)   3,731 3,658 10,186 10,070 9,803 9,378 798 798   Net Debt   3,616 3,531 9,692 9,169 8,538 8,152 -798 -798     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   167 284 173 848 920 814 0.0 0.0   Gross profit growth   438.7% 70.1% -39.1% 390.2% 8.5% -11.6% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,731 3,658 10,186 10,070 9,803 9,378 798 798   Balance sheet change%   -1.6% -2.0% 178.5% -1.1% -2.7% -4.3% -91.5% 0.0%   Added value   167.0 284.0 173.0 848.0 920.0 813.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -181 -146 5,162 749 -331 -309 -9,313 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   55.7% 73.9% 57.2% 80.5% 82.1% 79.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.4% 5.7% 1.4% 6.8% 7.6% 6.7% 0.0% 0.0%   ROI %   2.5% 5.8% 1.4% 6.8% 7.7% 6.8% 0.0% 0.0%   ROE %   -1.4% 1.9% -7.7% 45.8% 38.0% 7.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -2.1% -0.2% 3.3% 5.3% 8.0% 9.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,165.3% 1,243.3% 5,602.3% 1,081.3% 928.0% 1,001.9% 0.0% 0.0%   Gearing %   -4,625.3% -39,233.3% 2,893.5% 1,735.9% 1,098.5% 961.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 3.4% 4.5% 4.5% 4.8% 6.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.7 4.3 0.8 0.5 0.1 0.0 0.0   Current Ratio   0.5 0.7 4.3 0.8 0.5 0.1 0.0 0.0   Cash and cash equivalent   38.0 0.0 59.0 153.0 129.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -206.0 -76.0 1,141.0 -102.0 -302.0 -514.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 920 814 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 920 814 0 0   EBIT / employee   0 0 0 0 755 642 0 0   Net earnings / employee   0 0 0 0 252 59 0 0